13 Jun 2019 14:22
Collagen Solutions Plc
(the "Company")
Notice of Results
Analyst and Investor Briefing
Collagen Solutions plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, announces that it will issue its audited full year results for the year ended 31 March 2019 on Tuesday 9 July 2019.
Analyst briefing
An analyst briefing will take place at the offices of Walbrook PR, 4 Lombard Street, London, EC3V 9HD at 9.30am on Tuesday 9 July 2019.
Investor briefing
The Company will also be hosting an afternoon presentation for investors on Tuesday 9 July 2019, where Jamal Rushdy, CEO, and Hilary Spence, CFO, will summarise the full year results and discuss:
· The Company and its operations;
· Underlying business trends;
· Growth strategy;
· The recent placing and open offer;
· Outlook and key milestones.
This investor event will take place at the Copper Bar, upstairs at Balls Brothers, 6 Adams Court, Old Broad St, London, EC2N 1DX at 4.30pm for a 4.45pm start. This will be followed by drinks and canapes, and a chance to network.
If you would like to register for either the analyst or investor presentation, please contact Walbrook PR on 020 7933 8780 or email collagen@walbrookpr.com
Enquiries:
Collagen Solutions Plc | Contact via Walbrook | ||
Jamal Rushdy, CEO |
| ||
Hilary Spence, CFO |
| ||
|
| ||
Cenkos Securities plc (Nominated Adviser and Broker) Giles Balleny / Stephen Keys | Tel: 0207 397 8900
| ||
|
| ||
Walbrook PR Ltd | Tel: 020 7933 8780 or collagen@walbrookpr.com | ||
Anna Dunphy | Mob: 07876 741 001 | ||